Tasigna 150mg Capsule

Tasigna 150mg capsule is an antineoplastic drug with an active ingredient called Nilotinib. It belongs to the medication class known as tyrosine kinase inhibitors. This medicine is used to treat a type of leukemia called  Philadelphia chromosome-positive chronic myeloid leukemia (Ph-positive CML), a blood cancer with abnormal production of WBC. In adult and pediatric patients, it is used in a patient who is newly diagnosed with Chronic Myeloid Leukemia (CML) and those facing side effects from previous treatment. Additionally, it is also used in patients with no longer respond to the previous treatment including Imatinib.

Blood cancer (Philadelphia chromosome-positive chronic myeloid leukemia) in adults and pediatrics.

Take this medicine in the dose and duration as advised by your doctor. Tasigna 200mg Capsule is to be taken empty stomach.

BCR-ABL tyrosine kinase is responsible for the uncontrolled division of cells in the CML. Tasigna 150mg disrupts the signaling route of the protein kinase enzyme which targets the BCR-ABL protein and inhibits the growth and spread of cancer cells.

Side Effects of Tasigna 150mg Capsule

Store below 25°C

4 capsule*1 strip